(a) Mycelial diameter (mm) determination on PDA plates, (b) Inhibition diameters, and (c) inhibition percentages of <i>Aspergillus flavus</i> treated with <i>U. epigea</i> extract... by Martha Cebile Jobe (21175426)

Subjects:

Qualitative analyses of <i>U. epigea</i> bulb phytochemicals. by Martha Cebile Jobe (21175426)

Subjects:

Nucleotide sequence alignment of aflatoxin genes <i>Nor, Omt</i>, <i>Ver</i> and <i>aflR</i> treated with <i>U. epigea</i> extract, Ag/ZnO (Biosynthesized and Conventional) nanopar... by Martha Cebile Jobe (21175426)

Subjects:

<i>Aspergillus flavus</i> mRNA expression (a) <i>aflD</i> and (c) <i>aflR</i> and phylogenetic analysis of (b) <i>aflD</i> and (d) <i>aflR</i> after exposure to 50 mg/mL of <i>U. e... by Martha Cebile Jobe (21175426)

Subjects:

Primer pairs and PCR conditions used for amplification of selected Aflatoxin PCR gene primer pairs and their condition. by Martha Cebile Jobe (21175426)

Subjects:

In individuals affected by PCA, there is a significant downregulation of genes associated with the cholesterol biosynthetic pathway. by Leemon Nikhila (22250736)

Subjects:

Study Flowchart. by Jae-Heung Cho (798319)

Subjects:

(A) Cost-effectiveness plane in healthcare system perspectives; (B) Cost-effectiveness acceptability curve in healthcare system perspectives; (C) Cost-effectiveness plane in societ... by Jae-Heung Cho (798319)

Subjects:

Primary and secondary outcomes by treatment and time since randomization. by Jae-Heung Cho (798319)

Subjects:

Quality of life years after randomization into the <i>Chuna</i> manual therapy and usual care groups. by Jae-Heung Cho (798319)

Subjects:

Changes in outcomes over time. by Jae-Heung Cho (798319)

Subjects:

Baseline characteristics of participants by randomized group. by Jae-Heung Cho (798319)

Subjects:

Results of cost-effectiveness analysis of <i>Chuna</i> manual therapy compared with usual care^a. by Jae-Heung Cho (798319)

Subjects:

Study timetable. by Jae-Heung Cho (798319)

Subjects:

Cumulative incidence curves of recovery by group. by Jae-Heung Cho (798319)

Subjects:

The significant decrease in GLT-1 levels observed in the nucleus accumbens of rats that had consumed morphine for fifty-six days was completely reversed by the co-administration of NAC (40 mg/kg/day, i.p.) and ibudilast (7.5 mg/kg/day, i.p.). by María Elena Quintanilla (8068691)

Cat Stress Score (CSS) was significantly predicted by intake type and days in the study. by Allison Andrukonis (11846404)

eQTL analysis of significant SNPs. by Dai Nogimura (21445649)

Subjects:

Significant associations in the candidate gene approach. by Dai Nogimura (21445649)

Subjects:

Evogliptin attenuates the pyroptotic cell death of VSMCs during CER treatment by decreasing the pyroptotic-associated genes and GSDM-D cleavage efficiency <i>in-vitro.</i> by Razia Rashid Rahil (22772495)

“…<p>(A) Bar graph showed EVO significantly decreased Lactate dehydrogenase (LDH) release in CER treated P_i‐induced VSMCs. …”